
Briohealth Files for STAR Market IPO, Targets Global Artificial Heart Market
Chinese artificial heart company Briohealth has filed for a STAR Market IPO. Its next-generation device, BrioVAD, is in FDA trials and is positioned to challenge Abbott's long-standing monopoly in the global LVAD market.
12/29/20252 min read

